PharmaSGP Holding SE (PSG.DE)
EUR 24.8
(5.98%)
EUR 24.8
(5.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 131.29 Million EUR | 1.7% |
| 2022 | 129.1 Million EUR | 12.02% |
| 2021 | 115.25 Million EUR | 362.07% |
| 2020 | 24.94 Million EUR | -75.96% |
| 2019 | 103.74 Million EUR | 12.72% |
| 2018 | 92.03 Million EUR | 9.5% |
| 2017 | 84.05 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 134.15 Million EUR | -4.81% |
| 2024 Q1 | 140.92 Million EUR | 7.33% |
| 2023 Q4 | 131.29 Million EUR | -0.15% |
| 2023 Q1 | 133.55 Million EUR | 3.45% |
| 2023 Q2 | 132.79 Million EUR | -0.57% |
| 2023 FY | 131.29 Million EUR | 1.7% |
| 2023 Q3 | 131.49 Million EUR | -0.98% |
| 2022 Q3 | 125.5 Million EUR | 3.72% |
| 2022 Q1 | 119.34 Million EUR | 3.55% |
| 2022 FY | 129.1 Million EUR | 12.02% |
| 2022 Q4 | 129.1 Million EUR | 2.87% |
| 2022 Q2 | 121 Million EUR | 1.39% |
| 2021 Q2 | 28.03 Million EUR | 8.59% |
| 2021 FY | 115.25 Million EUR | 362.07% |
| 2021 Q4 | 115.25 Million EUR | -10.73% |
| 2021 Q3 | 129.11 Million EUR | 360.61% |
| 2021 Q1 | 25.81 Million EUR | 3.49% |
| 2020 Q1 | 109.09 Million EUR | 5.16% |
| 2020 FY | 24.94 Million EUR | -75.96% |
| 2020 Q4 | 24.94 Million EUR | 5.84% |
| 2020 Q3 | 23.56 Million EUR | -2.32% |
| 2020 Q2 | 24.12 Million EUR | -77.88% |
| 2019 FY | 103.74 Million EUR | 12.72% |
| 2019 Q1 | - EUR | 0.0% |
| 2019 Q4 | 103.74 Million EUR | 0.0% |
| 2018 FY | 92.03 Million EUR | 9.5% |
| 2017 FY | 84.05 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| MPH Health Care AG | 266.35 Million EUR | 50.705% |
| Apontis Pharma AG | 57.5 Million EUR | -128.346% |
| Dermapharm Holding SE | 2.18 Billion EUR | 93.987% |
| Evotec SE | 2.29 Billion EUR | 94.289% |
| MERCK Kommanditgesellschaft auf Aktien | 49.12 Billion EUR | 99.733% |
| SynBiotic SE | 34.91 Million EUR | -276.019% |